Page last updated: 2024-11-10

estrone sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

estrone sulfate: sulfoconjugated estrone; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3001028
CHEMBL ID494753
CHEBI ID17474
SCHEMBL ID22846
MeSH IDM0067972

Synonyms (66)

Synonym
BRD-K51095933-231-03-2
17-oxoestra-1,3,5(10)-trien-3-yl hydrogen sulfate
3-hydroxyestra-1,3,5(10)-trien-17-one hydrogen sulphate
estrone hydrogen sulfate
estrone sulfate
CHEBI:17474 ,
estrone sulphate
sodium estrone 3-monosulfate
PRESTWICK3_000688
BPBIO1_000897
NCGC00179418-01
estrone-3-sulfate
BSPBIO_000815
AB00514744
C02538
481-97-0
[(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
estra-1(10),2,4-trien-17-one, 3-(sulfooxy)-
estrone, hydrogen sulfate
estrone bisulfate
estrone-3-sulphate
estrone hemisulfate
DB04574
estra-1,3,5 (10)-triene-17-one-3-yl-sulfate
PRESTWICK2_000688
einecs 207-575-9
PRESTWICK0_000688
SPBIO_002736
PRESTWICK1_000688
CHEMBL494753
LMST02010043
bdbm50366524
unii-qtl48n278k
ccris 9319
qtl48n278k ,
us-2917522
estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-
price
conjugol
estrone sulfate [mi]
estradiol metabolite (e1s)
estrone 3 sulfate
estrone hydrogen sulphate
gtpl4749
[3h]estrone-3-sulphate
gtpl4748
[3h]-estrone-3-sulphate
[3h]estrone-3-sulfate
[(1s,10r,11s,15s)-15-methyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-trien-5-yl]oxidanesulfonic acid
[3h]-estrone hydrogen sulfate
SCHEMBL22846
estron-3-sulfate
estrone sulphate sodium
estrone hydrogen sulphate
estrone hydrogen sulfate
estrone 3-sulphate
sodium estrone 3-monosulphate
sodium estrone 3-sulphate
estrogenic substances
DTXSID50891501
Q5401864
HY-113293
CS-0059536
[(3as,3br,9bs,11as)-11a-methyl-1-oxo-1h,2h,3h,3ah,3bh,4h,5h,9bh,10h,11h,11ah-cyclopenta[a]phenanthren-7-yl]oxidanesulfonic acid
EN300-7481412
AKOS040755487

Research Excerpts

Effects

ExcerptReferenceRelevance
"Estrone sulfate (E1-S) has been shown to be quantitatively the most important estrogen in peripheral blood. "( [Tissue culture and estrogen, to clarify the roles of estrone sulfate].
Honjo, H; Kitawaki, J; Naitoh, K; Ogino, Y; Okada, H; Urabe, M; Yamamoto, T; Yasuda, J, 1989
)
1.97

Toxicity

ExcerptReferenceRelevance
" The incidence and severity of adverse events were assessed by physical examination and patient reporting."( Pilot study evaluating the pharmacokinetics, pharmacodynamics, and safety of the combination of exemestane and tamoxifen.
Asnis, AG; Duncan, B; Francis, D; Hortobagyi, GN; Rivera, E; Schaaf, LJ; Valero, V, 2004
)
0.32
" All drug-related adverse events were grades 1 or 2; none was unexpected."( Pilot study evaluating the pharmacokinetics, pharmacodynamics, and safety of the combination of exemestane and tamoxifen.
Asnis, AG; Duncan, B; Francis, D; Hortobagyi, GN; Rivera, E; Schaaf, LJ; Valero, V, 2004
)
0.32
" We used intent-to-treat analysis (N = 224) and compliant analysis (>95%; N = 208) to assess circulating hormone concentrations, adverse events, and endometrial thickness (via transvaginal ultrasound)."( Soy Isoflavones for Reducing Bone Loss Study: effects of a 3-year trial on hormones, adverse events, and endometrial thickness in postmenopausal women.
Alekel, DL; Beer, BS; Genschel, U; Hanson, LN; Hofmann, H; Koehler, KJ; Kurzer, MS; Peterson, CT; Van Loan, MD, 2015
)
0.42
" We find no evidence of treatment effects on endometrial thickness, adverse events, or circulating hormone concentrations, most notably thyroid function, across a 3-year period."( Soy Isoflavones for Reducing Bone Loss Study: effects of a 3-year trial on hormones, adverse events, and endometrial thickness in postmenopausal women.
Alekel, DL; Beer, BS; Genschel, U; Hanson, LN; Hofmann, H; Koehler, KJ; Kurzer, MS; Peterson, CT; Van Loan, MD, 2015
)
0.42

Pharmacokinetics

Estrone, estrone sulfate, and estradiol in plasma were measured as pharmacodynamic markers. Significantly lower systemic levels of estradio, Estrone, and Estrone Sulfate at both doses of the test product were observed compared with equivalent doses of reference product.

ExcerptReferenceRelevance
"To investigate the pharmacokinetic profiles of different doses of micronized 17 beta-estradiol administered by oral or sublingual routes."( Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol.
Bates, GW; Blauer, KL; Hansen, M; Lobo, R; Price, TM; Stanczyk, F, 1997
)
0.3
" We calculated pharmacokinetic parameters for estradiol (E2) and estrone (E1) of maximum serum concentration, time to maximum serum concentration, terminal half-life, area under the concentration curve, and oral clearance."( Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol.
Bates, GW; Blauer, KL; Hansen, M; Lobo, R; Price, TM; Stanczyk, F, 1997
)
0.3
" Clinical trials combining tamoxifen with letrozole or anastrazole have shown minor pharmacokinetic drug interactions."( Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer.
Cleary, JF; Havighurst, TC; Hutson, PR; Love, RR; Rogers, E, 2005
)
0.33
" Blood was collected for pharmacokinetic analysis after at least 4 months of receiving 20 mg tamoxifen daily."( Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer.
Cleary, JF; Havighurst, TC; Hutson, PR; Love, RR; Rogers, E, 2005
)
0.33
"There is no pharmacokinetic interaction between tamoxifen and exemestane."( Effect of exemestane on tamoxifen pharmacokinetics in postmenopausal women treated for breast cancer.
Cleary, JF; Havighurst, TC; Hutson, PR; Love, RR; Rogers, E, 2005
)
0.33
" There were no significant changes in the pharmacokinetic parameters of ticlopidine when it was coadministered with ginkgo biloba."( The effects of ergoloid mesylates and ginkgo biloba on the pharmacokinetics of ticlopidine.
Huang, JD; Lai, ML; Lu, WJ, 2006
)
0.33
" The objectives of this study were to examine the pharmacokinetic profile of letrozole in Japanese subjects and to identify factors that influence variability in the pharmacokinetics of letrozole using population pharmacokinetic (PPK) analysis."( Population pharmacokinetic analysis of letrozole in Japanese postmenopausal women.
Horie, T; Shitara, Y; Tanii, H, 2011
)
0.37
" Estrone, estrone sulfate, and estradiol in plasma were measured as pharmacodynamic markers."( Population pharmacokinetic analysis of letrozole in Japanese postmenopausal women.
Horie, T; Shitara, Y; Tanii, H, 2011
)
0.77
" Pharmacokinetic results suggest that simvastatin is not likely to compromise the activity of anastrozole."( Effect of simvastatin on the pharmacokinetics of anastrozole.
Bao, T; Blackford, AL; Stearns, V, 2012
)
0.38
"The design, synthesis, in vitro inhibitory potency, and pharmacokinetic (PK) profiles of Ko143 analogs are described."( Synthesis of a new inhibitor of breast cancer resistance protein with significantly improved pharmacokinetic profiles.
Chmielecki, J; Chuang, BC; Guan, MY; Li, Y; Liao, M; Plesescu, M; Prakash, SR; Woo, J; Xia, CQ; Yang, JJ, 2016
)
0.43
" Significantly lower systemic levels of estradiol, estrone, and estrone sulfate at both doses of the test product were observed compared with equivalent doses of the reference product, with lower AUC0-24 and Cmax and earlier tmax."( Pharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsule.
Amadio, JM; Bernick, BA; Mirkin, S; Pickar, JH, 2016
)
0.67

Compound-Compound Interactions

ExcerptReferenceRelevance
" Then, to explore the possibility of OATP1B1-mediated drug-drug interaction, we checked the inhibitory effects of various drugs on the pitavastatin uptake in OATP1B1-expressing cells and evaluated whether the in vitro inhibition was clinically significant or not."( Drug-drug interaction between pitavastatin and various drugs via OATP1B1.
Hirano, M; Maeda, K; Shitara, Y; Sugiyama, Y, 2006
)
0.33
"Hepatic uptake carriers of the organic anion-transporting peptide (OATP) family of solute carriers are more and more recognized as being involved in hepatic elimination of many drugs and potentially associated drug-drug interactions."( Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
Brun, ME; Funk, C; Noé, J; Portmann, R, 2007
)
0.34
" Because OATP2B1 exhibits an increasing number of drug substrates, including several statins, alterations of its function by PIs could result in clinically significant drug-drug interactions in the intestine."( pH dependence of organic anion-transporting polypeptide 2B1 in Caco-2 cells: potential role in antiretroviral drug oral bioavailability and drug-drug interactions.
Bendayan, R; Kis, O; Ramaswamy, M; Zastre, JA, 2010
)
0.36
"To support drug development, the drug-drug interaction potential (DDI) of an investigational drug (AZX) was assessed against the probe estradiol 17β-glucuronide as well as against simvastatin acid, atorvastatin, pravastatin, pitavastatin, fluvastatin, rosuvastatin and estrone 3-sulfate."( Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins.
Butters, CJ; Elsby, R; Sharma, P; Smith, V; Surry, D, 2012
)
0.38
"The hepatic organic anion transporting polypeptides (OATPs) influence the pharmacokinetics of several drug classes and are involved in many clinical drug-drug interactions."( Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR, 2012
)
0.38

Bioavailability

ExcerptReferenceRelevance
" Association of germfree rats with the cecal volume-reducing flora did not change the cecal absorption rate of estrone-3-sulfate, but shortened the 50% small intestinal transit time of [14C]PEG from 10 to 3 h; a value also found in conventional rats."( Influence of a cecal volume-reducing intestinal microflora on the excretion and entero-hepatic circulation of steroids and bile acids.
Caenepeel, P; Eyssen, H; Robben, J; Van Eldere, J, 1988
)
0.27
" Comparison of "areas under the curve" obtained with the present preparations to similar previous studies on ethinyl oestradiol indicated that the bioavailability of the non-ethinyl oestrogens is by more than one order of magnitude less than that of ethinyl oestradiol after oral administration."( Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
Bolt, HM; Göser, R; Hochlehnert, G; Schindler, AE; Zwirner, M, 1982
)
0.51
" Comparison of areas under the curve obtained with the present preparations similar to previous studies on ethinyl estradiol indicated that the bioavailability of the nonethinyl estrogens is by more than 1 order of magnitude less than that of ethinyl estradiol after oral administration."( Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
Bolt, HM; Göser, R; Hochlehnert, G; Schindler, AE; Zwirner, M, 1982
)
0.51
" The rate of absorption is however very much reduced compared to the non-sulphated steroid."( Gastrointestinal absorption of estrone sulfate in germfree and conventional rats.
Back, DJ; Eyssen, HJ; Huijghebaert, S; Sim, SM, 1983
)
0.55
" Overall, transdermal application leads to higher bioavailability of estradiol compared with the oral use of estrone/estrone sulfate or estradiol."( [Transdermal and oral hormone substitution with estrogens: a comparison].
Schindler, AE, 1995
)
0.5
" The present data suggest that estrogen sulfates can play an important biological role in the target tissues of the fetus, and that the enzymatic mechanisms of the bioavailability of E2 for the biological responses of the hormone can be operated in the target tissue itself."( Transformation of estrone, estradiol, and estrone sulfate in uterine and vaginal isolated cells of fetal guinea pig. Effect of various antiestrogens in the conversion of estrone sulfate to estradiol.
Chetrite, G; Pasqualini, JR; Urabe, M, 1993
)
0.55
" This difference may be attributed to the higher dosage of oral E2 that is required because of the low bioavailability compared with the transdermal dosages."( Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women.
Hodis, HN; Mack, WJ; Paulson, RJ; Shoupe, D; Slater, CC; Stanczyk, FZ,
)
0.43
" It also provides additional explanation why raloxifene has low bioavailability but a long half-life."( Disposition mechanisms of raloxifene in the human intestinal Caco-2 model.
Hu, M; Jeong, EJ; Lin, H, 2004
)
0.32
" In summary, ergoloid mesylates is a more potent inhibitor of OATP-B than is ginkgo biloba, and it can reduce the oral bioavailability of drugs transported by OATP-B."( The effects of ergoloid mesylates and ginkgo biloba on the pharmacokinetics of ticlopidine.
Huang, JD; Lai, ML; Lu, WJ, 2006
)
0.33
"The macrolide antibiotics azithromycin and clarithromycin are large molecular weight compounds that exhibit moderate to excellent oral bioavailability in preclinical species and humans."( Interaction of macrolide antibiotics with intestinally expressed human and rat organic anion-transporting polypeptides.
Davis, CB; Dawson, PA; Garver, E; Han, C; Haywood, J; Lan, T; Rao, A, 2009
)
0.35
" Compounds that alter transport by one or both of these OATPs could potentially be used to target drugs to hepatocytes or improve the bioavailability of drugs that are cleared by the liver."( Isolation of modulators of the liver-specific organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae).
Araya, JJ; Hagenbuch, B; Roth, M; Timmermann, BN, 2011
)
0.37
"4, suggesting that ABCG2 plays a role in limiting chlorothiazide bioavailability in humans."( ABCG2 modulates chlorothiazide permeability--in vitro-characterization of its interactions.
Abonyi, T; Bánsághi, S; Beéry, E; Erdő, F; Herédi-Szabó, K; Jani, M; Kis, E; Krajcsi, P; Makai, I; Márki-Zay, J; Rajnai, Z; Sziráki, I; Tóth, GK, 2012
)
0.38
"54L/h/kg] and higher bioavailability [123%])."( Synthesis of a new inhibitor of breast cancer resistance protein with significantly improved pharmacokinetic profiles.
Chmielecki, J; Chuang, BC; Guan, MY; Li, Y; Liao, M; Plesescu, M; Prakash, SR; Woo, J; Xia, CQ; Yang, JJ, 2016
)
0.43
"To evaluate the bioavailability and safety of a novel vaginal capsule containing solubilized bioidentical 17β-estradiol for vulvar and vaginal atrophy and compare its pharmacokinetics with that of an approved vaginal estradiol tablet in healthy postmenopausal women."( Pharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsule.
Amadio, JM; Bernick, BA; Mirkin, S; Pickar, JH, 2016
)
0.43
"Two randomized, single-dose, two-way cross-over, relative bioavailability trials compared the pharmacokinetics of a solubilized vaginal estradiol softgel capsule (TX-004HR, test) with that of a vaginal estradiol tablet (Vagifem®, reference) in postmenopausal women (aged 40-65 years) at 10-μg and 25-μg doses."( Pharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsule.
Amadio, JM; Bernick, BA; Mirkin, S; Pickar, JH, 2016
)
0.43
" Bioavailability of sulfated estrogens may contribute to relief of night sweats."( SLCO1B1 genetic variation and hormone therapy in menopausal women.
de Andrade, M; Dudenkov, T; Faubion, SS; Kapoor, E; Miller, VM; Moyer, AM; Weinshilboum, RM, 2018
)
0.48
" Even though many food additives are poorly absorbed into systemic circulation, high concentrations could exist in the intestinal lumen, making intestinal drug transporters, such as the uptake transporter organic anion transporting polypeptide 2B1 (OATP2B1), a possible site of food additive-drug interactions."( Food Additives as Inhibitors of Intestinal Drug Transporter OATP2B1.
Deng, F; Hagström, M; Kidron, H; Koenderink, JB; Pierrot, E; Sánchez, VB; Tikkanen, A, 2020
)
0.56

Dosage Studied

ExcerptRelevanceReference
" A dose-response relationship exists for serum levels achieved after oral E2 administration."( Pharmacokinetics of oral 17 beta-estradiol.
Cassidenti, DL; Lobo, RA, 1992
)
0.28
" On subsequent repeated dosing with PyG, both the Km (4."( Pharmacokinetics and pharmacodynamics of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione in patients with postmenopausal breast cancer.
Coombes, RC; Dowsett, M; Griggs, LJ; Haynes, BP; Jarman, M; Jones, A; Lønning, PE; Mehta, A; Powles, T; Stein, R, 1991
)
0.28
"In order to study the effect of Toxoplasma infection on hormonal levels in pregnant ewes, twenty-eight Scottish Blackface ewes were dosed orally with Toxoplasma gondii oocytes at 91 +/- 1 days of gestation."( The effect of Toxoplasma gondii infection in unvaccinated and iscom-vaccinated pregnant ewes as monitored by plasma levels of 15-ketodihydroprostaglandin F2 alpha, progesterone, and oestrone sulphate.
Buxton, D; Edqvist, LE; Fredriksson, G; Kindahl, H; Uggla, A, 1990
)
0.28
"625 mg daily, combined with 1000 mg elemental calcium supplementation, was the minimum effective dosage to prevent loss of spinal bone mineral density in postmenopausal women over a 12-month period."( Effect of estrone sulfate on postmenopausal bone loss.
Baylink, DJ; Gallagher, JC; Genant, HK; Harris, ST; Herber, M; Steiger, P, 1990
)
0.68
"A group of 13 cows were dosed orally nine or 10 days after a normal oestrous cycle; six animals received colostrum, five animals received milk containing varying amounts of oestrone sulphate, and two cows were given milk containing a low level of oestrone sulphate."( Effects on the oestrous cycle of dairy cows of the administration of colostrum in the mid-luteal phase.
Holdsworth, RJ; Turner, CB, 1984
)
0.27
" There was an indication that complete suppression of oestradiol and oestrone was not maintained throughout the 12-h dosing period, but the data and its interpretation are complicated by a minor diurnal rhythm in these parameters."( Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancer.
Coombes, RC; Dowsett, M; Moore, J; Powles, TJ; Rubens, R; Smith, IE; Smithers, D; Trunet, PF, 1994
)
0.29
" Dose-response analysis indicated an IC50 of 350 nM for (p-O-sulfamoyl)-N-tetradecanoyl tyramine for the inhibition of MDA-MB-231 estrone sulfatase activity."( Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
Hegde, PV; Li, PK; Selcer, KW, 1997
)
0.3
" Estrone levels did not vary with route of administration but correlated with the dosage administered."( Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol.
Bates, GW; Blauer, KL; Hansen, M; Lobo, R; Price, TM; Stanczyk, F, 1997
)
0.3
" This difference may be attributed to the higher dosage of oral E2 that is required because of the low bioavailability compared with the transdermal dosages."( Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women.
Hodis, HN; Mack, WJ; Paulson, RJ; Shoupe, D; Slater, CC; Stanczyk, FZ,
)
0.43
" Changing the capture antigen markedly influenced the dose-response lines."( Factors influencing the measurement of oestrone sulphate by dipstick particle capture immunoassay.
Henderson, K; Stewart, J, 2002
)
0.31
" Select compounds from the present series showed activity in vivo after oral dosing in rodent models of uterine proliferation."( Structure-activity relationships and sub-type selectivity in an oxabicyclic estrogen receptor alpha/beta agonist scaffold.
Allegretto, EA; Hamann, LG; Karanewsky, DS; Lopez, FJ; Marschke, KB; Meyer, JH; Ruppar, DA, 2005
)
0.33
" Dose-response studies in the same rat model demonstrated that more than 90% inhibition of STS activity in tumors was necessary to induce tumor shrinkage."( A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models.
Akinaga, S; Anazawa, H; Ishida, H; Kuwabara, T; Li, PK; Murakata, C; Nakata, T; Sato, N; Shiotsu, Y; Suzuki, M; Takebayashi, M; Tanaka, H; Terasaki, Y, 2007
)
0.34
" Levels of disulfated metabolites in serum and tissues were higher (3- to 5-fold) after multiple dosing than after a single dose."( Levels of tibolone and estradiol and their nonsulfated and sulfated metabolites in serum, myometrium, and vagina of postmenopausal women following treatment for 21 days with tibolone, estradiol, or estradiol plus medroxyprogestrone acetate.
Blok, LJ; Burger, CW; Hanifi-Moghaddam, P; Kloosterboer, HJ; Verheul, HA, 2007
)
0.34
" Previous concomitant dosing studies in rats using rifamycin SV, a general organic anion-transporting polypeptide (OATP) inhibitor, suggested that the high oral absorption of azithromycin and clarithromycin may be caused by facilitative uptake by intestinal Oatps."( Interaction of macrolide antibiotics with intestinally expressed human and rat organic anion-transporting polypeptides.
Davis, CB; Dawson, PA; Garver, E; Han, C; Haywood, J; Lan, T; Rao, A, 2009
)
0.35
"Fifty-eight women received either 10 microg or 25 microg estradiol vaginal tablets, administered once daily for 2 weeks, followed by twice-weekly dosing for 10 weeks."( Minimized estradiol absorption with ultra-low-dose 10 microg 17beta-estradiol vaginal tablets.
Eugster-Hausmann, M; Lehnick, D; Waitzinger, J, 2010
)
0.36
" Blood samples were collected scheduled intervals for 24 hours after the last dosing to determine plasma concentrations of atorvastatin acid, atorvastatin lactone, 2-hydroxy atorvastatin acid, and 2-hydroxy atorvastatin lactone."( The effect of the newly developed angiotensin receptor II antagonist fimasartan on the pharmacokinetics of atorvastatin in relation to OATP1B1 in healthy male volunteers.
Cho, JY; Jang, IJ; Kim, SE; Kim, TE; Lee, MG; Shin, KH; Shin, SG; Song, IS; Yoon, SH; Yu, KS, 2011
)
0.37
"Substances that compete for the same saturable intestinal transporters may when dosed together lead to altered permeability and hence influence bioavailability."( Simulating kinetic parameters in transporter mediated permeability across Caco-2 cells. A case study of estrone-3-sulfate.
Rapin, N; Rolsted, K; Steffansen, B, 2011
)
0.37
"Our objective was to assess metabolic effects of oral vs transdermal (TD) 17β-E₂ replacement using estrogen concentration-based dosing in girls with Turner syndrome (TS)."( Metabolic effects of oral versus transdermal 17β-estradiol (E₂): a randomized clinical trial in girls with Turner syndrome.
Hossain, J; Klein, KO; Mauras, N; Mericq, V; Ross, JL; Santen, RJ; Singh, R; Taboada, M; Torres-Santiago, L; Unanue, N, 2013
)
0.39
" Preclinical pharmacokinetic studies have demonstrated that most of the dosed TAK-475 was hydrolyzed to M-I during the absorption process and the concentrations of M-I in the liver, the main organ of cholesterol biosynthesis, were much higher than those in the plasma after oral administration to rats."( Characterization of Transporters in the Hepatic Uptake of TAK-475 M-I, a Squalene Synthase Inhibitor, in Rats and Humans.
Asahi, S; Ebihara, T; Kondo, T; Moriwaki, T; Moriya, Y; Tagawa, Y; Takeuchi, T, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
steroid sulfateA sulfuric ester obtained by the formal condensation of a hydroxy group of any steroid with sulfuric acid.
17-oxo steroidAny oxo steroid carrying the oxo group at position 17.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (13)

PathwayProteinsCompounds
Metabolism14961108
Biological oxidations150276
Phase II - Conjugation of compounds73122
Cytosolic sulfonation of small molecules1747
Sulfate/Sulfite Metabolism620
Androgen and Estrogen Metabolism1230
17-beta Hydroxysteroid Dehydrogenase III Deficiency1230
Sulfite Oxidase Deficiency620
Aromatase Deficiency1230
Estrone Metabolism1622
3q29 copy number variation syndrome012
Sulfatase and aromatase pathway1414
Estrogen metabolism025

Protein Targets (23)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Multidrug resistance-associated protein 4Homo sapiens (human)IC50 (µMol)70.00000.20005.677410.0000AID678790; AID678956
Steryl-sulfataseHomo sapiens (human)IC50 (µMol)7.60000.00010.40717.6000AID205760; AID70820
Steryl-sulfataseHomo sapiens (human)Ki60.00000.47000.62000.6700AID205777
Multidrug resistance-associated protein 1 Homo sapiens (human)Ki0.45000.07002.20208.1000AID679984
Solute carrier organic anion transporter family member 1A1Rattus norvegicus (Norway rat)Ki1.30001.10004.51259.8000AID681147
Solute carrier family 22 member 20Mus musculus (house mouse)Ki57.77201.10006.67899.1201AID360149
Solute carrier family 22 member 6Mus musculus (house mouse)Ki203.58700.40745.02179.4000AID360150
Solute carrier organic anion transporter family member 1C1Mus musculus (house mouse)Ki53.10000.27001.11002.1500AID681369
Solute carrier family 22 member 8Rattus norvegicus (Norway rat)Ki9.10003.09005.54009.1000AID679633
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)Ki0.04580.04401.36305.0000AID679506
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Solute carrier organic anion transporter family member 1A4Rattus norvegicus (Norway rat)Km11.00000.24003.28416.5300AID678788
Solute carrier organic anion transporter family member 1A5Rattus norvegicus (Norway rat)Km268.00004.30006.39608.8000AID681149
Solute carrier organic anion transporter family member 2B1 Homo sapiens (human)Km15.81400.70005.00608.0900AID679419; AID679428; AID679476; AID680320; AID699532
Steryl-sulfataseHomo sapiens (human)Km12.26670.80001.25001.7000AID205783; AID205784; AID205785
Sodium/bile acid cotransporterRattus norvegicus (Norway rat)Km27.00003.70005.36677.4000AID679119
Multidrug resistance-associated protein 1 Homo sapiens (human)Km0.73000.73002.65505.0000AID681068
Solute carrier organic anion transporter family member 1A1Rattus norvegicus (Norway rat)Km7.75000.01503.49967.0000AID681606; AID682135
Solute carrier organic anion transporter family member 1A2Homo sapiens (human)Km28.23336.40007.42009.6000AID1211305; AID1211318; AID679953
Solute carrier family 22 member 8Homo sapiens (human)Km10.05000.34501.32173.1000AID1219949; AID681141
Solute carrier organic anion transporter family memberBos taurus (cattle)Km23.42500.25000.25000.2500AID1211303; AID1211304
Solute carrier family 22 member 11Homo sapiens (human)Km1.01000.15400.62151.0100AID678971
Solute carrier organic anion transporter family member 1A1Mus musculus (house mouse)Km5.00005.00007.13338.2000AID681592
Solute carrier organic anion transporter family member 1B2Rattus norvegicus (Norway rat)Km37.00001.10005.28339.4500AID681150
Solute carrier family 22 member 8Rattus norvegicus (Norway rat)Km2.34000.73901.53952.3400AID678967
Broad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)Km11.90004.00005.40006.8000AID680971; AID681172
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)Km5.00030.00763.201810.0000AID679504; AID681365; AID682045
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (75)

Processvia Protein(s)Taxonomy
prostaglandin secretionMultidrug resistance-associated protein 4Homo sapiens (human)
cilium assemblyMultidrug resistance-associated protein 4Homo sapiens (human)
platelet degranulationMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic metabolic processMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
bile acid and bile salt transportMultidrug resistance-associated protein 4Homo sapiens (human)
prostaglandin transportMultidrug resistance-associated protein 4Homo sapiens (human)
urate transportMultidrug resistance-associated protein 4Homo sapiens (human)
glutathione transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
cAMP transportMultidrug resistance-associated protein 4Homo sapiens (human)
leukotriene transportMultidrug resistance-associated protein 4Homo sapiens (human)
monoatomic anion transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
export across plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
transport across blood-brain barrierMultidrug resistance-associated protein 4Homo sapiens (human)
guanine nucleotide transmembrane transportMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic metabolic processSolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
monoatomic ion transportSolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
organic anion transportSolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
prostaglandin transportSolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
heme catabolic processSolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
sodium-independent organic anion transportSolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
transmembrane transportSolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
transport across blood-brain barrierSolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
bile acid and bile salt transportSolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
steroid catabolic processSteryl-sulfataseHomo sapiens (human)
female pregnancySteryl-sulfataseHomo sapiens (human)
epidermis developmentSteryl-sulfataseHomo sapiens (human)
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
leukotriene metabolic processMultidrug resistance-associated protein 1 Homo sapiens (human)
xenobiotic metabolic processMultidrug resistance-associated protein 1 Homo sapiens (human)
response to xenobiotic stimulusMultidrug resistance-associated protein 1 Homo sapiens (human)
cobalamin transportMultidrug resistance-associated protein 1 Homo sapiens (human)
sphingolipid biosynthetic processMultidrug resistance-associated protein 1 Homo sapiens (human)
cellular response to oxidative stressMultidrug resistance-associated protein 1 Homo sapiens (human)
heme catabolic processMultidrug resistance-associated protein 1 Homo sapiens (human)
xenobiotic transportMultidrug resistance-associated protein 1 Homo sapiens (human)
phospholipid translocationMultidrug resistance-associated protein 1 Homo sapiens (human)
positive regulation of inflammatory responseMultidrug resistance-associated protein 1 Homo sapiens (human)
transmembrane transportMultidrug resistance-associated protein 1 Homo sapiens (human)
cell chemotaxisMultidrug resistance-associated protein 1 Homo sapiens (human)
transepithelial transportMultidrug resistance-associated protein 1 Homo sapiens (human)
cyclic nucleotide transportMultidrug resistance-associated protein 1 Homo sapiens (human)
leukotriene transportMultidrug resistance-associated protein 1 Homo sapiens (human)
monoatomic anion transmembrane transportMultidrug resistance-associated protein 1 Homo sapiens (human)
sphingolipid translocationMultidrug resistance-associated protein 1 Homo sapiens (human)
export across plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
transport across blood-brain barrierMultidrug resistance-associated protein 1 Homo sapiens (human)
cellular response to amyloid-betaMultidrug resistance-associated protein 1 Homo sapiens (human)
carboxylic acid transmembrane transportMultidrug resistance-associated protein 1 Homo sapiens (human)
xenobiotic transport across blood-brain barrierMultidrug resistance-associated protein 1 Homo sapiens (human)
glutathione transmembrane transportMultidrug resistance-associated protein 1 Homo sapiens (human)
xenobiotic metabolic processSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
monoatomic ion transportSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
organic cation transportSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
organic anion transportSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
bile acid and bile salt transportSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
sodium-independent organic anion transportSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
transmembrane transportSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
monoatomic ion transportSolute carrier family 22 member 8Homo sapiens (human)
response to toxic substanceSolute carrier family 22 member 8Homo sapiens (human)
inorganic anion transportSolute carrier family 22 member 8Homo sapiens (human)
prostaglandin transportSolute carrier family 22 member 8Homo sapiens (human)
xenobiotic transportSolute carrier family 22 member 8Homo sapiens (human)
transmembrane transportSolute carrier family 22 member 8Homo sapiens (human)
transport across blood-brain barrierSolute carrier family 22 member 8Homo sapiens (human)
monoatomic ion transportSolute carrier family 22 member 11Homo sapiens (human)
inorganic anion transportSolute carrier family 22 member 11Homo sapiens (human)
organic anion transportSolute carrier family 22 member 11Homo sapiens (human)
prostaglandin transportSolute carrier family 22 member 11Homo sapiens (human)
urate metabolic processSolute carrier family 22 member 11Homo sapiens (human)
transmembrane transportSolute carrier family 22 member 11Homo sapiens (human)
lipid transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
biotin transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
sphingolipid biosynthetic processBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
riboflavin transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate metabolic processBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transmembrane transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transepithelial transportBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
renal urate salt excretionBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
export across plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
transport across blood-brain barrierBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
cellular detoxificationBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic transport across blood-brain barrierBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic metabolic processSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
monoatomic ion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
organic anion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
bile acid and bile salt transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
prostaglandin transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
heme catabolic processSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
sodium-independent organic anion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
transmembrane transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
thyroid hormone transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (47)

Processvia Protein(s)Taxonomy
guanine nucleotide transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
protein bindingMultidrug resistance-associated protein 4Homo sapiens (human)
ATP bindingMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type xenobiotic transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
prostaglandin transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
urate transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
purine nucleotide transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type bile acid transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
efflux transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
15-hydroxyprostaglandin dehydrogenase (NAD+) activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATP hydrolysis activityMultidrug resistance-associated protein 4Homo sapiens (human)
glutathione transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATPase-coupled transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
xenobiotic transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
ABC-type transporter activityMultidrug resistance-associated protein 4Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
transmembrane transporter activitySolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
bile acid transmembrane transporter activitySolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
steryl-sulfatase activitySteryl-sulfataseHomo sapiens (human)
sulfuric ester hydrolase activitySteryl-sulfataseHomo sapiens (human)
metal ion bindingSteryl-sulfataseHomo sapiens (human)
arylsulfatase activitySteryl-sulfataseHomo sapiens (human)
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ATP bindingMultidrug resistance-associated protein 1 Homo sapiens (human)
ABC-type vitamin B12 transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ABC-type glutathione S-conjugate transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
efflux transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ATP hydrolysis activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ATPase-coupled lipid transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
glutathione transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ATPase-coupled transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
xenobiotic transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
sphingolipid transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
carboxylic acid transmembrane transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ABC-type transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
ABC-type xenobiotic transporter activityMultidrug resistance-associated protein 1 Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1A2Homo sapiens (human)
organic cation transmembrane transporter activitySolute carrier organic anion transporter family member 1A2Homo sapiens (human)
bile acid transmembrane transporter activitySolute carrier organic anion transporter family member 1A2Homo sapiens (human)
transmembrane transporter activitySolute carrier organic anion transporter family member 1A2Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1A2Homo sapiens (human)
solute:inorganic anion antiporter activitySolute carrier family 22 member 8Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier family 22 member 8Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier family 22 member 8Homo sapiens (human)
xenobiotic transmembrane transporter activitySolute carrier family 22 member 8Homo sapiens (human)
solute:inorganic anion antiporter activitySolute carrier family 22 member 11Homo sapiens (human)
protein bindingSolute carrier family 22 member 11Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier family 22 member 11Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier family 22 member 11Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier family 22 member 11Homo sapiens (human)
protein bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATP bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ABC-type xenobiotic transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
urate transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
biotin transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
efflux transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATP hydrolysis activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
riboflavin transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
ATPase-coupled transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
identical protein bindingBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
protein homodimerization activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
xenobiotic transmembrane transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
sphingolipid transporter activityBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
bile acid transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
thyroid hormone transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (31)

Processvia Protein(s)Taxonomy
nucleolusMultidrug resistance-associated protein 4Homo sapiens (human)
Golgi apparatusMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
membraneMultidrug resistance-associated protein 4Homo sapiens (human)
basolateral plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
apical plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
platelet dense granule membraneMultidrug resistance-associated protein 4Homo sapiens (human)
external side of apical plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 4Homo sapiens (human)
plasma membraneSolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
basal plasma membraneSolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
apical plasma membraneSolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
basolateral plasma membraneSolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
apical plasma membraneSolute carrier organic anion transporter family member 2B1 Homo sapiens (human)
lysosomeSteryl-sulfataseHomo sapiens (human)
endosomeSteryl-sulfataseHomo sapiens (human)
endoplasmic reticulumSteryl-sulfataseHomo sapiens (human)
endoplasmic reticulum lumenSteryl-sulfataseHomo sapiens (human)
endoplasmic reticulum membraneSteryl-sulfataseHomo sapiens (human)
Golgi apparatusSteryl-sulfataseHomo sapiens (human)
plasma membraneSteryl-sulfataseHomo sapiens (human)
membraneSteryl-sulfataseHomo sapiens (human)
intracellular membrane-bounded organelleSteryl-sulfataseHomo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
basal plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
basolateral plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
apical plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
lateral plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
extracellular exosomeMultidrug resistance-associated protein 1 Homo sapiens (human)
basolateral plasma membraneMultidrug resistance-associated protein 1 Homo sapiens (human)
plasma membraneSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
basal plasma membraneSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
apical plasma membraneSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
basolateral plasma membraneSolute carrier organic anion transporter family member 1A2Homo sapiens (human)
plasma membraneSolute carrier family 22 member 8Homo sapiens (human)
basolateral plasma membraneSolute carrier family 22 member 8Homo sapiens (human)
apical plasma membraneSolute carrier family 22 member 8Homo sapiens (human)
extracellular exosomeSolute carrier family 22 member 8Homo sapiens (human)
plasma membraneSolute carrier family 22 member 11Homo sapiens (human)
external side of plasma membraneSolute carrier family 22 member 11Homo sapiens (human)
basal plasma membraneSolute carrier family 22 member 11Homo sapiens (human)
apical plasma membraneSolute carrier family 22 member 11Homo sapiens (human)
extracellular exosomeSolute carrier family 22 member 11Homo sapiens (human)
nucleoplasmBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
apical plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
brush border membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
mitochondrial membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
membrane raftBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
external side of apical plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneBroad substrate specificity ATP-binding cassette transporter ABCG2Homo sapiens (human)
plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
basal plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
basolateral plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (172)

Assay IDTitleYearJournalArticle
AID679119TP_TRANSPORTER: uptake in Ntcp-expressing CHO cells1998The American journal of physiology, 02, Volume: 274, Issue:2
Substrate specificity of the rat liver Na(+)-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells.
AID1220862Efflux ratio of permeability from apical to basolateral over basolateral to apical side in vector transfected human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID1079938Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]
AID537736Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID681597TP_TRANSPORTER: cell accumulation in OST-expressing oocytes2003The Journal of biological chemistry, Jul-25, Volume: 278, Issue:30
Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta.
AID681151TP_TRANSPORTER: uptake in Xenopus laevis oocytes2001Gastroenterology, Feb, Volume: 120, Issue:2
Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver.
AID1079946Presence of at least one case with successful reintroduction. [column 'REINT' in source]
AID360151Ratio of pKi for mouse Oat1 expressed in Xenopus oocytes to pKi for mouse Oat6 expressed in Xenopus oocytes2007The Journal of biological chemistry, Aug-17, Volume: 282, Issue:33
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
AID588968Substrates of transporters of clinical importance in the absorption and disposition of drugs, OATP2B12010Nature reviews. Drug discovery, Mar, Volume: 9, Issue:3
Membrane transporters in drug development.
AID678788TP_TRANSPORTER: uptake in Xenopus laevis oocytes1997Proceedings of the National Academy of Sciences of the United States of America, Sep-16, Volume: 94, Issue:19
Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain.
AID1079942Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]
AID205783Michaelis-Menten constant steroid sulfatase (STS) was determined2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
The difluoromethylene group as a replacement for the labile oxygen in steroid sulfates: a new approach to steroid sulfatase inhibitors.
AID680025TP_TRANSPORTER: inhibition of Deltorphin II uptake (Deltorphin II: 50 uM, E1S: 150 uM) in Xenopus laevis oocytes2000The Journal of pharmacology and experimental therapeutics, Jul, Volume: 294, Issue:1
Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier.
AID678826TP_TRANSPORTER: uptake in Oatp1-expressing COS-7 cells1999The Journal of pharmacology and experimental therapeutics, Feb, Volume: 288, Issue:2
Contribution of organic anion transporting polypeptide to uptake of its possible substrates into rat hepatocytes.
AID679633TP_TRANSPORTER: inhibition of PCG uptake in OAT3-expressing LLC-PK1 cells2002Molecular pharmacology, May, Volume: 61, Issue:5
Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus.
AID360150Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr2007The Journal of biological chemistry, Aug-17, Volume: 282, Issue:33
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
AID537734Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID1079936Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]
AID681150TP_TRANSPORTER: uptake in Xenopus laevis oocytes2001Pflugers Archiv : European journal of physiology, Nov, Volume: 443, Issue:2
Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3.
AID681172TP_TRANSPORTER: uptake (vesicle) in membrane vesicles from ABCG2-expressing P388 cells2003The Journal of biological chemistry, Jun-20, Volume: 278, Issue:25
ABCG2 transports sulfated conjugates of steroids and xenobiotics.
AID1220870Efflux ratio of permeability from apical to basolateral over basolateral to apical side in BCRP knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis relative to2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID1211307Cellular uptake in HEK293 cells assessed as bovine high affinity site of OATP1A2-mediated drug uptake at 50 nM at pH 6 after 1 min2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID1211313Cellular uptake in HEK293 cells assessed as bovine OATP1A2-mediated drug uptake at 50 nM in presence of taurocholate2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID1219948Drug transport in human OAT3 expressed in HEK Flp-In cells assessed as maximal rate of transport measured per mg of protein2012Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 40, Issue:3
Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs.
AID1215923Efflux ratio of permeability from basolateral to apical side to apical to basolateral side in MDCK2 cells expressing OATP1B1 (unknown origin) at 1 uM after 30 to 180 mins by LC-MS/MS analysis2013Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 41, Issue:5
Involvement of organic anion-transporting polypeptides in the hepatic uptake of dioscin in rats and humans.
AID1220869Efflux ratio of permeability from apical to basolateral over basolateral to apical side in BCRP knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID1220861Apparent permeability from basolateral to apical side of MRP2 knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID1211301Cellular uptake in HEK293 cells assessed as bovine OATP1A2-mediated drug uptake at 100 nM up to 2 mins by liquid scintillation counting2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID678847TP_TRANSPORTER: inhibition of (Ochratoxin A: 0.5uM) of Estrone-3-sulfate at a concentration of 100uM in Oat5-expressing oocytes2004American journal of physiology. Renal physiology, Aug, Volume: 287, Issue:2
Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney.
AID682135TP_TRANSPORTER: uptake in Oatp1-expressing CHO-03 cell1999The American journal of physiology, 04, Volume: 276, Issue:4
Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells.
AID360152Activity of mouse Oat6 expressed in Xenopus oocytes assessed as drug uptake2007The Journal of biological chemistry, Aug-17, Volume: 282, Issue:33
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
AID1220884Apparent permeability from apical to basolateral side of vector transfected human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1220872Efflux ratio of permeability from apical to basolateral over basolateral to apical side in MRP2 knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID1211309Cellular uptake in HEK293 cells assessed as bovine low affinity site of OATP1A2-mediated drug uptake at 50 uM at pH 6 after 1 min2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID681593TP_TRANSPORTER: uptake in OATP8-expressing HEK293 cells2001The Journal of biological chemistry, Mar-30, Volume: 276, Issue:13
Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6.
AID681135TP_TRANSPORTER: uptake in OATP-F-expressing CHO cells2002Molecular endocrinology (Baltimore, Md.), Oct, Volume: 16, Issue:10
Identification of a novel human organic anion transporting polypeptide as a high affinity thyroxine transporter.
AID679475TP_TRANSPORTER: uptake in Xenopus laevis oocytes2001Gastroenterology, Feb, Volume: 120, Issue:2
Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver.
AID1211299Cellular uptake in HEK293 cells assessed as bovine OATP1A2-mediated drug uptake at 100 nM by liquid scintillation counting2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID360149Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr2007The Journal of biological chemistry, Aug-17, Volume: 282, Issue:33
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
AID1079935Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]
AID679304TP_TRANSPORTER: Transepithelial Transport (basal to apical) in OATP1B1/MRP2 double transfected LLC-PK1 cell2005Biochemical pharmacology, Feb-01, Volume: 69, Issue:3
Directional trans-epithelial transport of organic anions in porcine LLC-PK1 cells that co-express human OATP1B1 (OATP-C) and MRP2.
AID1211316Cellular uptake in HEK293 cells assessed as bovine OATP1A2-mediated drug uptake at 50 uM in presence of rifampicin2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID1211303Cellular uptake in HEK293 cells assessed as bovine high affinity site of OATP1A2-mediated drug uptake at 0.01 to 50 uM after 1 min by Eadie-Hofstee plot analysis2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID70846In vitro binding affinity against estrone sulfatase in rat liver microsomes1999Bioorganic & medicinal chemistry letters, Jan-18, Volume: 9, Issue:2
Synthesis and sulfatase inhibitory activities of (E)- and (Z)-4-hydroxytamoxifen sulfamates.
AID1220864Apparent permeability from basolateral to apical side of P-gp knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID681386TP_TRANSPORTER: uptake in mOat3-expressing oocytes2004Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 32, Issue:5
Renal transport of organic compounds mediated by mouse organic anion transporter 3 (mOat3): further substrate specificity of mOat3.
AID1211314Cellular uptake in HEK293 cells assessed as bovine OATP1A2-mediated drug uptake at 50 uM in presence of taurocholate2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID1219949Drug transport in human OAT3 expressed in HEK Flp-In cells2012Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 40, Issue:3
Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs.
AID1079939Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]
AID679136TP_TRANSPORTER: Transepithelial Transport (basal to apical) in OATP1B1/MDR1 double transfected MDCKII cells2005The Journal of pharmacology and experimental therapeutics, Sep, Volume: 314, Issue:3
Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multid
AID1079945Animal toxicity known. [column 'TOXIC' in source]
AID1220871Apparent permeability from apical to basolateral side of MRP2 knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID1221735Drug uptake ratio assessed as enzyme-mediated uptake in HEK293 cells expressing human OATP1B1 at 10 uM at 37 degC for 3 mins by liquid scintillation spectroscopy relative to wild type2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Characterization of digoxin uptake in sandwich-cultured human hepatocytes.
AID681168TP_TRANSPORTER: uptake in Oat3-expressing oocyte cells2004The Journal of pharmacology and experimental therapeutics, Jun, Volume: 309, Issue:3
Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier.
AID1220885Apparent permeability from basolateral to apical side of vector transfected human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID1624948Substrate activity at Helix pomatia arylsulfatase assessed as enzyme-mediated compound hydrolysis by measuring catalytic efficiency by UPLC-MS/MS analysis2019Bioorganic & medicinal chemistry, 03-15, Volume: 27, Issue:6
Comprehensive kinetic and substrate specificity analysis of an arylsulfatase from Helix pomatia using mass spectrometry.
AID679504TP_TRANSPORTER: uptake in Xenopus laevis oocytes2001Pharmaceutical research, Sep, Volume: 18, Issue:9
Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C.
AID537733Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID1220865Efflux ratio of permeability from apical to basolateral over basolateral to apical side in P-gp knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID678974TP_TRANSPORTER: cell accumulation in OATP8-expressing HEK293 cells2004The Journal of pharmacology and experimental therapeutics, Oct, Volume: 311, Issue:1
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans.
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1211317Cellular uptake in HEK293 cells assessed as bovine OATP1A2-mediated drug uptake at 50 uM in presence of methotrexate2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID1079932Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]
AID681606TP_TRANSPORTER: uptake in Xenopus laevis oocytes1996The Journal of pharmacology and experimental therapeutics, Mar, Volume: 276, Issue:3
Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver.
AID1079940Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]
AID1215924Efflux ratio of permeability from basolateral to apical side to apical to basolateral side in MDCK2 cells expressing OATP1B1/MRP2 (unknown origin) at 1 uM after 30 to 180 mins by LC-MS/MS analysis2013Drug metabolism and disposition: the biological fate of chemicals, May, Volume: 41, Issue:5
Involvement of organic anion-transporting polypeptides in the hepatic uptake of dioscin in rats and humans.
AID681346TP_TRANSPORTER: ATP-dependent uptake in membrane vesicle from MRP8-expressing LLC-PK1 cells2005Molecular pharmacology, Feb, Volume: 67, Issue:2
Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11).
AID682045TP_TRANSPORTER: uptake in OATP-C-expressing HEK293 cells2001Pharmaceutical research, Sep, Volume: 18, Issue:9
Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C.
AID699540Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID588962Substrates of transporters of clinical importance in the absorption and disposition of drugs, OATP1B12010Nature reviews. Drug discovery, Mar, Volume: 9, Issue:3
Membrane transporters in drug development.
AID1079934Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]
AID679476TP_TRANSPORTER: uptake (pH 5.0) in OATP-B-expressing HEK293 cells2004The Journal of pharmacology and experimental therapeutics, Feb, Volume: 308, Issue:2
Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human.
AID1079943Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]
AID681365TP_TRANSPORTER: uptake in OATP-C-expressing HEK293 cells2001The Journal of biological chemistry, Mar-30, Volume: 276, Issue:13
Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6.
AID680030TP_TRANSPORTER: inhibition of DHEAS uptake (DHEAS: 5 uM, E1S: 100 uM) in Xenopus laevis oocytes1998FEBS letters, Mar-13, Volume: 424, Issue:3
Dehydroepiandrosterone sulfate (DHEAS): identification of a carrier protein in human liver and brain.
AID1079931Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]
AID223690Inhibitory activity against protein tyrosine phosphatases (PTP1B) (Kis=slope inhibitory constant)2000Journal of medicinal chemistry, Jan-27, Volume: 43, Issue:2
Structure-based discovery of small molecule inhibitors targeted to protein tyrosine phosphatase 1B.
AID588967Substrates of transporters of clinical importance in the absorption and disposition of drugs, OATP1A22010Nature reviews. Drug discovery, Mar, Volume: 9, Issue:3
Membrane transporters in drug development.
AID682206TP_TRANSPORTER: inhibition of E217betaG uptake (E217betaG: 0.1 uM, E1S: 500 uM) in membrane vesicle from Mrp3-expressing LLC-PK1 cells1999The Journal of biological chemistry, May-21, Volume: 274, Issue:21
Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3).
AID1221734Drug uptake ratio assessed as enzyme-mediated uptake in HEK293 cells expressing human OATP2B1 at 1 uM at 37 degC for 3 mins by liquid scintillation spectroscopy relative to wild type2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Characterization of digoxin uptake in sandwich-cultured human hepatocytes.
AID1211310Cellular uptake in HEK293 cells assessed as bovine low affinity site of OATP1A2-mediated drug uptake at 50 uM at pH 7.4 after 1 min2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID680466TP_TRANSPORTER: inhibition of Enalapril uptake (Enalapril: ? uM, E1S: 100 uM) in Oatp1-expressing HeLa cells1998Hepatology (Baltimore, Md.), Nov, Volume: 28, Issue:5
The modified dipeptide, enalapril, an angiotensin-converting enzyme inhibitor, is transported by the rat liver organic anion transport protein.
AID1079933Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is
AID205777Inhibitory activity against steroid sulfatase (STS) desulfation of 4-MUS2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
The difluoromethylene group as a replacement for the labile oxygen in steroid sulfates: a new approach to steroid sulfatase inhibitors.
AID1624946Substrate activity at Helix pomatia arylsulfatase assessed as enzyme-mediated compound hydrolysis by measuring Vmax by UPLC-MS/MS analysis2019Bioorganic & medicinal chemistry, 03-15, Volume: 27, Issue:6
Comprehensive kinetic and substrate specificity analysis of an arylsulfatase from Helix pomatia using mass spectrometry.
AID1221737Drug uptake ratio assessed as enzyme-mediated uptake in HEK293 cells expressing human OATP2B1 at 10 uM at 37 degC for 3 mins by liquid scintillation spectroscopy relative to wild type2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Characterization of digoxin uptake in sandwich-cultured human hepatocytes.
AID681595TP_TRANSPORTER: uptake in Xenopus laevis oocytes2002Biochimica et biophysica acta, Aug-19, Volume: 1564, Issue:1
Functional characterization of the mouse organic-anion-transporting polypeptide 2.
AID1624942Stability of the compound in pH 7 ammonium acetate buffer by UPLC-MS/MS analysis2019Bioorganic & medicinal chemistry, 03-15, Volume: 27, Issue:6
Comprehensive kinetic and substrate specificity analysis of an arylsulfatase from Helix pomatia using mass spectrometry.
AID1624947Substrate activity at Helix pomatia arylsulfatase assessed as enzyme-mediated compound hydrolysis by measuring Kcat by UPLC-MS/MS analysis2019Bioorganic & medicinal chemistry, 03-15, Volume: 27, Issue:6
Comprehensive kinetic and substrate specificity analysis of an arylsulfatase from Helix pomatia using mass spectrometry.
AID247015Effect on uterine wet weight in ovariectomized female rats after 30 mg/kg oral gavage dose2005Bioorganic & medicinal chemistry letters, Mar-01, Volume: 15, Issue:5
Structure-activity relationships and sub-type selectivity in an oxabicyclic estrogen receptor alpha/beta agonist scaffold.
AID1624945Substrate activity at Helix pomatia arylsulfatase assessed as enzyme-mediated compound hydrolysis by measuring Km by UPLC-MS/MS analysis2019Bioorganic & medicinal chemistry, 03-15, Volume: 27, Issue:6
Comprehensive kinetic and substrate specificity analysis of an arylsulfatase from Helix pomatia using mass spectrometry.
AID681592TP_TRANSPORTER: uptake in Xenopus laevis oocytes2000The Biochemical journal, Jan-01, Volume: 345 Pt 1Molecular cloning and functional characterization of the mouse organic-anion-transporting polypeptide 1 (Oatp1) and mapping of the gene to chromosome X.
AID678790TP_TRANSPORTER: inhibition of DHEAS in membrane vesicles from MRP4-expressing Sf9 cells2003The Biochemical journal, Apr-15, Volume: 371, Issue:Pt 2
Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4).
AID678979TP_TRANSPORTER: uptake in OATP-E-expressing HEK293 cells2000Biochemical and biophysical research communications, Jun-24, Volume: 273, Issue:1
Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.
AID681602TP_TRANSPORTER: uptake in Xenopus laevis oocytes1997Hepatology (Baltimore, Md.), Dec, Volume: 26, Issue:6
Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver.
AID1211308Cellular uptake in HEK293 cells assessed as bovine high affinity site of OATP1A2-mediated drug uptake at 50 nM at pH 7.4 after 1 min2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID1219950Transport efficiency, ratio of maximal rate of transport to Km for drug transport in human OAT3 expressed in HEK Flp-In cells measured per mg of protein2012Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 40, Issue:3
Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs.
AID679168TP_TRANSPORTER: cell accumulation in OATP2-expressing HEK293 cells2004The Journal of pharmacology and experimental therapeutics, Oct, Volume: 311, Issue:1
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans.
AID679419TP_TRANSPORTER: uptake in OATP-B-expressing HEK293 cells2001Pharmaceutical research, Sep, Volume: 18, Issue:9
Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C.
AID205760Inhibition of steroid sulfatase activity of JEG-3 cells2000Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.
AID1079947Comments (NB not yet translated). [column 'COMMENTAIRES' in source]
AID1219953Drug transport in human OAT3 expressed in HEK Flp-In cells at 0.01 uM for 10 mins relative to control2012Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 40, Issue:3
Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs.
AID679477TP_TRANSPORTER: uptake in Xenopus laevis oocytes2002The Journal of biological chemistry, Jul-26, Volume: 277, Issue:30
Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice.
AID205785Michaelis-Menten constant was determined against sulfatase in HEK293 cells2000Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.
AID679508TP_TRANSPORTER: cell accumulation in OATP-C-expressing Xenopus oocytes2004Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 32, Issue:3
Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity.
AID1211318Cellular uptake in Xenopus oocytes cells assessed as OATP1A2 (unknown origin)-mediated drug uptake2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID678956TP_TRANSPORTER: inhibition of E217betaG uptake in membrane vesicles from MRP4-expressing Sf9 cells2003The Biochemical journal, Apr-15, Volume: 371, Issue:Pt 2
Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4).
AID404304Effect on human MRP2-mediated estradiol-17-beta-glucuronide transport in Sf9 cells inverted membrane vesicles relative to control2008Journal of medicinal chemistry, Jun-12, Volume: 51, Issue:11
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
AID1079941Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]
AID1079937Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]
AID679428TP_TRANSPORTER: uptake (pH 7.4) in OATP-B-expressing HEK293 cells2004The Journal of pharmacology and experimental therapeutics, Feb, Volume: 308, Issue:2
Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human.
AID679376TP_TRANSPORTER: uptake in Xenopus laevis oocytes2002The Journal of biological chemistry, Jul-26, Volume: 277, Issue:30
Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice.
AID360153Activity of mouse Oat1 expressed in Xenopus oocytes assessed as drug uptake2007The Journal of biological chemistry, Aug-17, Volume: 282, Issue:33
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.
AID681068TP_TRANSPORTER: uptake, in the presence of GSH (GSH: 1mM) in membrane vesicle from MRP1-expressing HeLa cells2001The Journal of biological chemistry, Mar-02, Volume: 276, Issue:9
Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1.
AID679331TP_TRANSPORTER: uptake in Oatp1-expressing Saccharomyces cerevisiae secretory vesicle2003American journal of physiology. Gastrointestinal and liver physiology, Aug, Volume: 285, Issue:2
N-glycosylation controls functional activity of Oatp1, an organic anion transporter.
AID1221732Drug uptake ratio assessed as enzyme-mediated uptake in HEK293 cells expressing human OATP1B1 at 1 uM at 37 degC for 3 mins by liquid scintillation spectroscopy relative to wild type2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Characterization of digoxin uptake in sandwich-cultured human hepatocytes.
AID1220868Apparent permeability from basolateral to apical side of BCRP knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID1069338Inhibition of VGLUT in rat brain assessed as [3H]-L-Glu uptake into synaptic vesicles at 250 uM relative to control2014Bioorganic & medicinal chemistry letters, Feb-01, Volume: 24, Issue:3
The development of benzo- and naphtho-fused quinoline-2,4-dicarboxylic acids as vesicular glutamate transporter (VGLUT) inhibitors reveals a possible role for neuroactive steroids.
AID205774Inhibition of steroid sulfatase activity of JEG-3 cells by the compound at 20 uM, activity was determined by considering total labeled estrone ([3H]E1) formed from labeled estrone sulfate ([3H]-E1S)2000Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.
AID1211305Cellular uptake in HEK293 cells assessed as human OATP1A2-mediated drug uptake at 0.05 uM after 1 min by Eadie-Hofstee plot analysis2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID1220873Efflux ratio of permeability from apical to basolateral over basolateral to apical side in MRP2 knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis relative to2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID1220866Efflux ratio of permeability from apical to basolateral over basolateral to apical side in P-gp knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis relative to2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID681149TP_TRANSPORTER: uptake in Xenopus laevis oocytes2001Pflugers Archiv : European journal of physiology, Nov, Volume: 443, Issue:2
Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3.
AID699532Activity at human liver OATP2B1 expressed in HEK293 Flp-In cells2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID678971TP_TRANSPORTER: uptake in Xenopus laevis oocytes2000The Journal of biological chemistry, Feb-11, Volume: 275, Issue:6
Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta.
AID682056TP_TRANSPORTER: uptake (pH 5.0) of Estrone-3-sulfate at a concentration of 5.43 nM in OATP-B-expressing HEK293 cells2004The Journal of pharmacology and experimental therapeutics, Feb, Volume: 308, Issue:2
Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human.
AID1079944Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]
AID1079948Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]
AID679174TP_TRANSPORTER: uptake in OATP-D-expressing HEK293 cells2000Biochemical and biophysical research communications, Jun-24, Volume: 273, Issue:1
Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.
AID1211304Cellular uptake in HEK293 cells assessed as bovine low affinity site of OATP1A2-mediated drug uptake at 0.01 to 50 uM after 1 min by Eadie-Hofstee plot analysis2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID681598TP_TRANSPORTER: cell accumulation in OST-expressing oocytes2003The Journal of biological chemistry, Jul-25, Volume: 278, Issue:30
Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta.
AID679506TP_TRANSPORTER: inhibition of E217betaG uptake in OATP-C-expressing HEK293 cells2001Pharmaceutical research, Sep, Volume: 18, Issue:9
Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C.
AID699541Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID1220863Apparent permeability from apical to basolateral side of P-gp knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID678966TP_TRANSPORTER: Transepithelial Transport (basal to apical) in OATP1B1/BCRP double transfected MDCKII cells2005The Journal of pharmacology and experimental therapeutics, Sep, Volume: 314, Issue:3
Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multid
AID678985TP_TRANSPORTER: Transepithelial Transport (basal to apical) in OATP1B1/MRP2 double transfected MDCKII cells2005The Journal of pharmacology and experimental therapeutics, Sep, Volume: 314, Issue:3
Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multid
AID1069337Inhibition of VGLUT-mediated [3H]-L-Glu uptake into synaptic vesicles in rat brain2014Bioorganic & medicinal chemistry letters, Feb-01, Volume: 24, Issue:3
The development of benzo- and naphtho-fused quinoline-2,4-dicarboxylic acids as vesicular glutamate transporter (VGLUT) inhibitors reveals a possible role for neuroactive steroids.
AID682027TP_TRANSPORTER: uptake in Oatp1-expressing HeLa cells1998Hepatology (Baltimore, Md.), Nov, Volume: 28, Issue:5
The modified dipeptide, enalapril, an angiotensin-converting enzyme inhibitor, is transported by the rat liver organic anion transport protein.
AID681147TP_TRANSPORTER: inhibition of E217betaG uptake in Oatp1-expressing HeLa cells1996The American journal of physiology, Feb, Volume: 270, Issue:2 Pt 2
Estradiol 17 beta-D-glucuronide is a high-affinity substrate for oatp organic anion transporter.
AID680971TP_TRANSPORTER: uptake in membrane vesicle from BCRP-expressing K562 cells2003Molecular pharmacology, Sep, Volume: 64, Issue:3
Breast cancer resistance protein exports sulfated estrogens but not free estrogens.
AID681549TP_TRANSPORTER: inhibition of Taurocholate uptake (Taurocholate: 2.5 uM, E1S: 200 uM) in Ntcp-expressing CHO cells1998The American journal of physiology, 02, Volume: 274, Issue:2
Substrate specificity of the rat liver Na(+)-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells.
AID699538Ratio of Vmax to Km for human liver OATP2B1 expressed in HEK293 Flp-In cells assessed per mg protein2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID699539Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID680320TP_TRANSPORTER: uptake in OATP2B1-expressing HEK293 cells2005Drug metabolism and disposition: the biological fate of chemicals, Apr, Volume: 33, Issue:4
Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B.
AID679424TP_TRANSPORTER: uptake (pH 7.4) of Estrone-3-sulfate at a concentration of 5.43 nM in OATP-B-expressing HEK293 cells2004The Journal of pharmacology and experimental therapeutics, Feb, Volume: 308, Issue:2
Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human.
AID1624943Substrate activity at Helix pomatia arylsulfatase assessed as enzyme-mediated compound hydrolysis using 1 U of enzyme measured after 30 mins by UPLC-MS/MS analysis2019Bioorganic & medicinal chemistry, 03-15, Volume: 27, Issue:6
Comprehensive kinetic and substrate specificity analysis of an arylsulfatase from Helix pomatia using mass spectrometry.
AID682174TP_TRANSPORTER: inhibition of benzylpenicillin uptake by Estrone-3-sulfate at a concentration of 1000uM in Oat3-expressing oocyte cells2004The Journal of pharmacology and experimental therapeutics, Jun, Volume: 309, Issue:3
Mouse reduced in osteosclerosis transporter functions as an organic anion transporter 3 and is localized at abluminal membrane of blood-brain barrier.
AID679167TP_TRANSPORTER: inhibition of DPDPE uptake (DPDPE: 0.02 uM) in Xenopus laevis oocytes2003The Journal of pharmacy and pharmacology, Jul, Volume: 55, Issue:7
Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2, D-Leu5]-enkephalin.
AID681141TP_TRANSPORTER: uptake in Xenopus laevis oocytes2001Molecular pharmacology, May, Volume: 59, Issue:5
Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney.
AID588965Substrates of transporters of clinical importance in the absorption and disposition of drugs, OAT32010Nature reviews. Drug discovery, Mar, Volume: 9, Issue:3
Membrane transporters in drug development.
AID679984TP_TRANSPORTER: inhibition of LTC4 uptake in membrane vesicle from MRP1-expressing HeLa cells2001The Journal of biological chemistry, Mar-02, Volume: 276, Issue:9
Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1.
AID680442TP_TRANSPORTER: inhibition of Ouabain uptake (Ouabain: 100 uM, E1S: 100 uM) in Xenopus laevis oocytes1996The Journal of pharmacology and experimental therapeutics, Mar, Volume: 276, Issue:3
Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver.
AID680972TP_TRANSPORTER: uptake in BCRP-expressing LLC-PK1 cells2003Molecular pharmacology, Sep, Volume: 64, Issue:3
Breast cancer resistance protein exports sulfated estrogens but not free estrogens.
AID205784Michaelis-Menten constant was determined against human placental steroid sulfatase2000Journal of medicinal chemistry, Nov-16, Volume: 43, Issue:23
Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.
AID680385TP_TRANSPORTER: cell accumulation in OATP8-expressing Xenopus oocytes2004Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 32, Issue:3
Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity.
AID678967TP_TRANSPORTER: uptake in Xenopus laevis oocytes1999The Journal of biological chemistry, May-07, Volume: 274, Issue:19
Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain.
AID679429TP_TRANSPORTER: uptake (pH 7.4) in OATP-B-expressing HEK293 cells2003The Journal of pharmacology and experimental therapeutics, Aug, Volume: 306, Issue:2
Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane.
AID681369TP_TRANSPORTER: inhibition of L-T4 uptake in Oatp14-expressing HEK293 cells2004Endocrinology, Sep, Volume: 145, Issue:9
Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier.
AID699535Activity at human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as rate of compound transport per mg of protein2012Journal of medicinal chemistry, May-24, Volume: 55, Issue:10
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
AID681418TP_TRANSPORTER: inhibition of Homovanillic acid uptake (HVA: 0.2 uM, E1S; 1000 uM) in Xenopus laevis oocytes2003Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, Apr, Volume: 23, Issue:4
Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID1211315Cellular uptake in HEK293 cells assessed as bovine OATP1A2-mediated drug uptake at 50 uM in presence of bromosulfophthalein2013Drug metabolism and disposition: the biological fate of chemicals, Mar, Volume: 41, Issue:3
Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2.
AID680452TP_TRANSPORTER: inhibition of Ochratoxin A uptake (OTA: 1 uM, E1S: 100uM) in Xenopus laevis oocytes1996The Journal of pharmacology and experimental therapeutics, Dec, Volume: 279, Issue:3
Uptake of the mycotoxin ochratoxin A in liver cells occurs via the cloned organic anion transporting polypeptide.
AID1220867Apparent permeability from apical to basolateral side of BCRP knockdown human Caco2 cells at 10 uM up to 120 mins by reverse-phase liquid chromatography with triple-quadrupole tandem mass spectrometry analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jul, Volume: 39, Issue:7
Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
AID70820Estrone sulfatase activity against homogenized human JEG-3 cells was determined by measuring the [3H]E1 obtained from [3H]E1S1998Bioorganic & medicinal chemistry letters, Jul-21, Volume: 8, Issue:14
17 alpha-alkyl- or 17 alpha-substituted benzyl-17 beta-estradiols: a new family of estrone-sulfatase inhibitors.
AID537735Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID679953TP_TRANSPORTER: uptake in Xenopus laevis oocytes1996Journal of hepatology, Nov, Volume: 25, Issue:5
Multispecific amphipathic substrate transport by an organic anion transporter of human liver.
AID1079949Proposed mechanism(s) of liver damage. [column 'MEC' in source]
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1345178Human OATP1B1 (SLCO family of organic anion transporting polypeptides)2010Current chemical genomics, Mar-01, Volume: 4Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides 1B1 and 1B3.
AID1802450Oatp1d1 Transport Assay from Article 10.1074/jbc.M113.518506: \\Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide.\\2013The Journal of biological chemistry, Nov-22, Volume: 288, Issue:47
Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (892)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990214 (23.99)18.7374
1990's184 (20.63)18.2507
2000's265 (29.71)29.6817
2010's213 (23.88)24.3611
2020's16 (1.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.37 (24.57)
Research Supply Index6.90 (2.92)
Research Growth Index4.50 (4.65)
Search Engine Demand Index47.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials70 (7.56%)5.53%
Reviews21 (2.27%)6.00%
Case Studies5 (0.54%)4.05%
Observational1 (0.11%)0.25%
Other829 (89.52%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]